Ticker

ROIV

Roivant Sciences Ltd.

8 catalysts on file

ROIV

Roivant Sciences Ltd.

Phase 2 Confirmed

brepocitinib

lichen planopilaris

196d ago Feb 6, 2026

SEC 8-K verified 2mo ago

Countdown card →

ROIV

Roivant Sciences Ltd.

Catalyst Confirmed

brepocitinib

dermatomyositis

196d ago Feb 6, 2026

SEC 8-K verified 2mo ago

Countdown card →

ROIV

Priovant Therapeutics

PDUFA Confirmed

brepocitinib

dermatomyositis

T-minus 40 days ~ Sep 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

ROIV

Roivant Sciences Ltd.

Phase 3 AI-extracted

brepocitinib

lichen planopilaris

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

ROIV

Roivant Sciences Ltd.

Phase 1 AI-extracted

IMVT-1402

difficult-to-treat rheumatoid arthritis

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

ROIV

Roivant Sciences Ltd.

Phase 2 AI-extracted

mosliciguat

pulmonary hypertension associated with interstitial lung disease

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

ROIV

Roivant Sciences Ltd.

Phase 3 AI-extracted

batoclimab

thyroid eye disease

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

ROIV

Roivant Sciences Ltd.

Phase 2 AI-extracted

IMVT-1402

Graves’ disease

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →